(Q37576100)

21 August 2017

1 reference

title

The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease (English)

1 reference

21 August 2017

1 reference

2

Anil Nigam

1 reference

21 August 2017

4

Jean-Claude Tardif

1 reference

21 August 2017

Philippe Meyer

1

1 reference

21 August 2017

Michel Marcil

series ordinal

3

1 reference

21 August 2017

publication date

1 September 2009

1 reference

Current Atherosclerosis Reports

21 August 2017

published in

1 reference

21 August 2017

volume

11

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

329-333

1 reference

Familial lipoprotein disorders in patients with premature coronary artery disease

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0049-Z

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0049-Z

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0049-Z

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0049-Z

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0049-Z

Prognostic significance of progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0049-Z

Intramural Delivery of Recombinant Apolipoprotein A-I Milano /Phospholipid Complex (ETC-216) Inhibits In-Stent Stenosis in Porcine Coronary Arteries

21 January 2018

1 reference

12 December 2020

Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins

1 reference

12 December 2020

High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization

1 reference

12 December 2020

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits

1 reference

12 December 2020

Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice

1 reference

12 December 2020

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

12 December 2020

Molecular regulation of HDL metabolism and function: implications for novel therapies

1 reference

12 December 2020

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

1 reference

12 December 2020

Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans

1 reference

12 December 2020

Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide

1 reference

12 December 2020

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits

1 reference

12 December 2020

Endothelial and antithrombotic actions of HDL.

1 reference

12 December 2020

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

1 reference

12 December 2020

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

12 December 2020

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits

1 reference

12 December 2020

Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells

1 reference

12 December 2020

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

12 December 2020

Antiinflammatory properties of HDL.

1 reference

12 December 2020

A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.

1 reference

12 December 2020

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

1 reference

12 December 2020

D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice

1 reference

12 December 2020

Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

1 reference

12 December 2020

Artificial HDL as an anti-atherosclerotic drug

1 reference

12 December 2020

Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine

1 reference

12 December 2020

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

1 reference

12 December 2020

Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets

1 reference

12 December 2020

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

12 December 2020

High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

1 reference

12 December 2020

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

1 reference

12 December 2020

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

12 December 2020

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

1 reference

12 December 2020

Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex

1 reference

12 December 2020

Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I.

1 reference

12 December 2020

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

1 reference

12 December 2020

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.

1 reference

12 December 2020

Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells

1 reference

12 December 2020

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis

1 reference

12 December 2020

Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans

1 reference

12 December 2020

HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk

1 reference

12 December 2020

10.1007/S11883-009-0049-Z

Identifiers

DOI

1 reference

21 August 2017

1 reference